Home/Filings/4/0001144204-18-062799
4//SEC Filing

Achenbach Brian 4

Accession 0001144204-18-062799

CIK 0001680048other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 12:47 PM ET

Size

10.1 KB

Accession

0001144204-18-062799

Insider Transaction Report

Form 4
Period: 2018-02-02
Achenbach Brian
VP, Fin. & Corp. Controller
Transactions
  • Purchase

    COMMON STOCK

    2018-11-16$4.31/sh+1,000$4,31056,000 total
  • Purchase

    COMMON STOCK

    2018-11-19$4.25/sh+1,000$4,25057,000 total
  • Purchase

    COMMON STOCK

    2018-11-20$3.87/sh+500$1,93757,500 total
  • Award

    COMMON STOCK

    2018-02-02+55,00055,000 total
Footnotes (2)
  • [F1]55,000 shares are restricted Common Stock which vest over various time periods.
  • [F2]Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on November 16, 2018 was $4.15 to $4.3792, and the range of prices for the purchase transactions on November 19, 2018 was $4.15 to $4.35. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Issuer

MUSTANG BIO, INC.

CIK 0001680048

Entity typeother

Related Parties

1
  • filerCIK 0001760132

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 12:47 PM ET
Size
10.1 KB